Immuneering Corporation
IMRX
$3.96
-$0.08-1.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.46M | -11.58M | -14.96M | -14.43M | -15.05M |
| Total Depreciation and Amortization | 88.70K | 83.20K | 86.20K | 91.80K | 92.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.32M | 1.57M | 1.54M | 1.61M | 1.78M |
| Change in Net Operating Assets | -6.39M | 82.60K | 1.36M | 3.29M | -902.50K |
| Cash from Operations | -18.43M | -9.84M | -11.98M | -9.45M | -14.08M |
| Capital Expenditure | -79.90K | -123.90K | -7.30K | -2.10K | -8.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.99M | -88.60M | -- | -- | -- |
| Cash from Investing | -63.07M | -88.72M | -7.30K | -2.10K | -8.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 180.80K | 429.80K | 216.27M | 2.10K | 13.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -787.40K | -3.07M | -64.00K | -- |
| Cash from Financing | 180.80K | -357.50K | 213.19M | -62.00K | 13.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -81.32M | -98.92M | 201.21M | -9.51M | -279.00K |